Asa Biopharm's Podcast

  • Autor: Vários
  • Narrador: Vários
  • Editor: Podcast
  • Duración: 76:12:21
  • Mas informaciones

Informações:

Sinopsis

In this podcast series sponsored by Biopharmaceutical Section of American Statistical Association, key opinion leaders from pharmaceutical industry and regulatory agencies talk about upcoming statistical conferences and events, and discuss current issues in Biopharmaceutical statistics.

Episodios

  • Episode 53: Abuse Deterrent Opioids

    31/05/2018 Duración: 43min

    Ling Chen and Kunthel By discuss methods related to the development of abuse deterrent opioids.

  • Episode 52: ASA Accreditation

    27/04/2018 Duración: 01h10min

    Zoltan Harsanyi, Janet McDougall, and Theresa Utlaut discuss the PStat® and GStat® accreditations.

  • Episode 51: The Effective Statistician

    28/03/2018 Duración: 46min

    Alexander Schacht and Benjamin Piske discuss their new podcast and the many ways statisticians can make themselves more effective.

  • Episode 50: Lisa LaVange

    21/02/2018 Duración: 50min

    ASA President Lisa LaVange describes her varied career across industry, government and academia, and discusses the establishment of the ASA Leadership Institute.

  • Episode 49: Heather Thomas

    25/01/2018 Duración: 47min

    Heather discusses her goals for the Biopharmaceutical Section in 2018 and describes the life of a medical product statistician living in a non-traditional area.

  • Episode 48: PhUSE, the Pharmaceutical Users Software Exchange

    02/12/2017 Duración: 51min

    Stephen Bamford, Chris Hurley and James Johnson discuss the motivation for and initiatives of PhUSE

  • Episode 47: Pediatric Medical Product Development

    06/11/2017 Duración: 45min

    Susan Wang and Amy Xia discuss the challenges of pediatric medical product development.

  • Episode 46: Re-Randomization of Subjects Scientific Working Group

    15/10/2017 Duración: 53min

    Gheorghe Doros, Anastasia Ivanova, and George Papakostas discuss the Sequential Parallel Comparison Design and the newly-formed Clinical Trial Designs with Re-Randomization of Subjects Scientific Working Group.

  • Episode 45: Kelly Zou

    19/09/2017 Duración: 24min

    Kelly shares her thoughts on real world data and real world evidence in the healthcare and pharmaceutical industry.

  • Episode 44: Weili He and Martin Ho

    17/08/2017 Duración: 35min

    Weili and Martin discuss the 2017 Regulatory-Industry Statistics Workshop.

  • Episode 43: 40th Anniversary of PSI

    27/07/2017 Duración: 47min

    Andy Grieve, Nigel Howitt, John Lewis and Lucy Rowell reminisce about PSI’s past and look forward to its future.

  • Episode 42: Committee on Minorities in Statistics

    29/06/2017 Duración: 47min

    Reneé Moore and Janelle Charles discuss the mission and major initiatives of the Committee on Minorities in Statistics and the many ways statisticians can get involved.

  • Episode 41: Liz Stuart

    05/06/2017 Duración: 42min

    Liz discusses the Health Policy Statistics Section (HPSS) of the ASA, the upcoming 2018 International Conference on Health Policy Statistics (ICHPS), as well as some of the major topic areas of focus for health policy statistics.

  • Episode 40: Estimands

    08/05/2017 Duración: 56min

    Yuki Ando, Frank Bretz, Rob Hemmings and Tom Permutt discuss estimands and the ICH E9 revisions.

  • Episode 39: Alex Dmitrienko

    14/03/2017 Duración: 58min

    Alex discusses multiplicity, the FDA’s draft guidance on multiple endpoints, and the BIOP pilot online training program.

  • Episode 38: Amanda Golbeck

    20/02/2017 Duración: 33min

    Amanda discusses statistical leadership and her book Leadership and Women in Statistics.

  • Episode 37: Multiregional Clinical Trials

    26/01/2017 Duración: 01h01min

    Aloka Chakravarty, Laurie Letvak and Bill Wang discuss MRCTs and the draft ICH E17 guidance.

  • Episode 36: Statistical Leadership

    21/12/2016 Duración: 59min

    Sonia Davis, Bill Sollecito and Paula Brown Stafford discuss statistical leadership and leadership training at the University of North Carolina at Chapel Hill.

  • Episode 35: EFSPI Benefit-Risk Working Group

    10/11/2016 Duración: 44min

    Alexander Schacht and Ian Hirsch discuss benefit-risk and the efforts of the EFSPI working group.

  • Episode 34: Patient Preferences in Medical Product Evaluation

    07/10/2016 Duración: 45min

    Telba Irony and Martin Ho discuss the important of patient preferences.

página 4 de 6